Condition: Primary Knee Osteoarthritis · Sponsor: Enlivex Therapeutics Ltd.
This is a multicenter, randomized, double-blind, placebo-controlled, Phase IIb study to evaluate intra-articular (IA) injections of Allocetra in participants with moderate-to-severe age related symptomatic primary knee osteoarthritis (OA).
This description comes directly from the study's public registry record.
Lior Binder · +972-54-8054599 · lior@enlivex.com
Lital Weinfeld Bergman · lital@enlivex.com
Always discuss trial participation with your own doctor first.
| Future Medical Research | Longwood, Florida, United States | Recruiting |
| South Florida Research Phase I-IV | Miami, Florida, United States | Recruiting |
| DelRicht Research @ Touro Medical Center | New Orleans, Louisiana, United States | Recruiting |
| Oakland Medical Research | Troy, Michigan, United States | Recruiting |
| Sanos Clinic Gandrup | Gandrup, Denmark | Recruiting |
| Sanos Clinic Herlev | Herlev, Denmark | Recruiting |
| Sanos Clinic Vejle | Vejle, Denmark | Recruiting |
| NZOZ Bif-Med. s.c | Bytom, Poland | Not Yet Recruiting |
| Vita Longa Sp. z o.o. | Katowice, Poland | Not Yet Recruiting |
| Centrum Medyczne PLEJADY | Krakow, Poland | Not Yet Recruiting |
| Medyczne Centrum Hetmańska | Poznan, Poland | Not Yet Recruiting |
| Reumedika sp. z o.o. | Poznan, Poland | Not Yet Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07580716